The authors concluded that low-dose aspirin during in vitro fertilisation may increase clinical pregnancy rates but that more research is required; there was no reason to discontinue aspirin use. Evidence appeared to support the authors' conclusions, but incomplete reporting of review methods and lack of assessment of study quality make it difficult to comment on their reliability.
Authors' objectives
To evaluate the effects of low-dose aspirin during in vitro fertilisation and compare findings with those of a previous meta-analysis.
Searching
MEDLINE, Web of Science, EMBASE, TOXLINE, DART (Developmental and Reproductive Toxicology database) and the Cochrane Database of Systematic Reviews were searched from inception to February 2007. Search terms were reported. In addition, reference lists of selected studies were handsearched. Only studies with an English language abstract were included.
Study selection
Prospective controlled trials (including randomised controlled trials (RCTs) and matched controlled trials) that evaluated low-dose aspirin (less than 150mg) during in vitro fertilisation or intracytoplasmic sperm injection were eligible for inclusion. Studies that evaluated aspirin combined with other drug treatments were excluded. The review assessed pregnancy rates, implantation rates and miscarriage rates.
The included studies compared aspirin (75 to 100mg) with placebo or no treatment. Included studies commenced and discontinued treatment at different points of the treatment or pregnancy cycle (details were reported).
Two reviewers independently selected studies. Disagreements were resolved with the help of a third reviewer.
Assessment of study quality
The authors did not state that they assessed validity.
Data extraction
For each study, data required to create 2x2 tables were extracted, and risk ratios (RR) and 95% confidence intervals (CI) were calculated.
The authors did not state how data were extracted for the review, or how many reviewers performed the data extraction.
Methods of synthesis
Pooled risk ratios and 95% confidence intervals were calculated using the fixed-effect Mantel-Haenszel method. Studies were weighted by sample size. Heterogeneity was assessed using the χ 2 (taking p>0.05 as indicative of homogeneity) and the I 2 statistics. Results of random-effects meta-analyses were also reported. Subgroup analysis was used to re-analyse data including only studies using fresh embryo transfer and only including studies in the metaanalysis conducted by Gelbaya et al (for reference see Other Publications of Related Interest field). The analysis by Gelbaya excluded conference abstracts, subgroups of infertile patients and studies using frozen embryo transfer.
